[183 Pages Report] The Veterinary Vaccines Market size was estimated at USD 9.82 billion in 2023 and expected to reach USD 10.40 billion in 2024, at a CAGR 6.43% to reach USD 15.19 billion by 2030.
Veterinary vaccines are biologically prepared substances that stimulate an animal's immune system to protect it from specific diseases. These vaccines function similarly to human vaccines by introducing antigens, typically inactivated or attenuated forms of pathogens or their components, into the animal's body. This exposure triggers an immune response, including producing antibodies, memory cells, and other defense mechanisms, so the animal can develop immunity to the targeted disease without getting sick. Increasing pet adoption, livestock population, rising awareness of zoonotic diseases, surging incidences of animal diseases, and escalating investments in animal health drive further growth. However, the high cost of vaccine storage and difficulties in maintaining the viability of vaccines during transport pose significant issues in the market expansion. The increasing count of in-house pets escalated the focus on food safety, and advancements in biotechnological research provide significant opportunities in the market.
The Americas exhibits the highest adoption of veterinary vaccines, primarily due to the high animal population and increasing awareness of animal health. Various regulations and guidelines set by local animal health organizations have substantially driven vaccine adoption. In EMEA, Europe leads in adopting veterinary vaccines owing to the region's advanced medical and technological infrastructure, robust regulatory frameworks, and initiatives promoting animal welfare, significantly contributing to this growth. In the Middle East and Africa, increasing investments and efforts towards improving animal health care systems signify growth potential. APAC, home to a large livestock population and high pet ownership, presents significant potential for veterinary vaccine adoption. Rapid urbanization and increasing pet adoption rates facilitate market expansion alongside governmental directives on disease prevention. The APAC Countries have been increasingly focusing on animal health as urban areas report high vaccine adoption due to increasing companion animal ownership and awareness.
![Veterinary Vaccines Market Veterinary Vaccines Market](https://dmqpwgwn6vmm8.cloudfront.net/dimension/veterinary-vaccines-statistics.png?t=1725740356000)
Market Dynamics
The market dynamics represent an ever-changing landscape of the Veterinary Vaccines Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
- Market Drivers
- Increasing number of companion animal and livestock ownership
- Rising incidence of chronic diseases and accidental injuries in animals
- Government initiatives for immunization of veterinary animals
- Market Restraints
- High cost associated with development, storage, and handling of vaccines
- Market Opportunities
- Shift from live attenuated vaccines to DNA vaccines
- Rising investments and R&D for development of novel veterinary vaccines
- Market Challenges
- Concerns associated with stringent regulatory compliance
Market Segmentation Analysis
Animal Type: Rising usage of vaccines for disease prevention in livestock animals
Aquaculture utilizes vaccines to ensure the health and productivity of aquatic species. The need for vaccines has increased in recent years due to the growing prevalence of diseases in both marine and freshwater environments. Fish health issues have led farmers to opt for vaccines, driving a preference for inactivated and toxic vaccines. The vaccine requirements for companion animals are largely preventive, ensuring the well-being of pets such as cats, dogs, and birds. Livestock vaccination is crucial for the avoidance of disease outbreaks, the protection of animal health, and the sustenance of productivity in the meat and dairy industries.
Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
Inactivated vaccines, also known as killed vaccines, are composed of virus particles, bacteria, and other pathogens that have been grown in culture and then killed. These vaccines are often employed in veterinary practices where live viruses pose a risk. They are specifically designed to target diseases such as rabies, influenza, and leptospirosis. Live attenuated vaccines are powerful tools in controlling infectious diseases in animals. They contain a version of the living microbe that has been altered so it cannot cause serious disease. They closely mimic natural infections and offer prolonged, usually lifelong immunity. Recombinant vaccines use a small piece of genetic material from a pathogen to stimulate an immune response. They offer enhanced safety and efficacy and are especially useful in the fight against infectious diseases such as Equine Influenza, Lyme Disease, and Avian Influenza. Toxoid vaccines are made from a toxin that has been made harmless, but that provokes an immune response against the toxin. These are ideally used to immunize against diseases that are caused by bacteria-release toxins.
Porter’s Five Forces Analysis
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Veterinary Vaccines Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Veterinary Vaccines Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Veterinary Vaccines Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Recent Developments
Merck Animal Health launches 3-in-one swine vaccine
Merck introduced an innovative three-in-one vaccine, Circumvent CML, for Veterinary Vaccines. This groundbreaking vaccine effectively controls Porcine Circovirus Type 2a and 2d, Mycoplasma hyopneumoniae, and Lawsonia intracellularis diseases. It offers the added convenience of reduced volume in a single-dose administration, making it easier for producers to administer. [Published On: June 14, 2023]
IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
Indian Immunologicals Ltd (IIL) is making a substantial investment of INR 700 crore to establish a state-of-the-art veterinary vaccine manufacturing facility in Hyderabad's Genome Valley. This greenfield facility focuses on producing vaccines for animal conditions such as foot and mouth disease and other emerging diseases. Once operational, the manufacturing plant will significantly increase IIL's FMD vaccine capacity from 300 million doses per annum to an impressive 600 million doses per annum. [Published On: October 11, 2022]
Merck Animal Health to Acquire Venc
Merck Animal Health has recently announced the signing of a definitive agreement to acquire Vence, developed virtual fencing for livestock management and rotational grazing in the context of veterinary vaccines. Vence's virtual fencing technology offers numerous benefits, including reducing the need for physical fencing and labor. It enables producers and ranchers to efficiently manage cattle movement and facilitate rotational grazing, all from the convenience of a computer or smartphone. [Published On: September 22, 2022]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Veterinary Vaccines Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..
Market Segmentation & Coverage
This research report categorizes the Veterinary Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Animal Type
- Aquaculture
- Companion Animals
- Livestock
- Bovine
- Porcine
- Poultry
- Small Ruminants
- Technology
- Inactivated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Route of Administration
- Intravenous
- Nasal
- Oral
- Distribution Channel
- Hospitals & Clinics
- Retail Pharmacies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
This research report offers invaluable insights into various crucial aspects of the Veterinary Vaccines Market:
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Veterinary Vaccines Market, by Animal Type
- Veterinary Vaccines Market, by Technology
- Veterinary Vaccines Market, by Route of Administration
- Veterinary Vaccines Market, by Distribution Channel
- Americas Veterinary Vaccines Market
- Asia-Pacific Veterinary Vaccines Market
- Europe, Middle East & Africa Veterinary Vaccines Market
- Competitive Landscape
- List of Figures [Total: 23]
- List of Tables [Total: 469]
- List of Companies Mentioned [Total: 29]
- How big is the Veterinary Vaccines Market?
- What is the Veterinary Vaccines Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?